MACRO
BRENTWTINAT GASGOLDSILVERPLATINUMPALLADIUMGOLD/SILVERCOPPERGASOLINECOCOAOJCANOLAS&P 500NASDAQDXYFED RATEBTCTASIDFMADXBRENTWTINAT GASGOLDSILVERPLATINUMPALLADIUMGOLD/SILVERCOPPERGASOLINECOCOAOJCANOLAS&P 500NASDAQDXYFED RATEBTCTASIDFMADX
96

Miral Dental Clinics Co.

9604XSAU
Saudi Exchange·Healthcare
SAR 102.00
▼︎ 2.02%(-2.10)
Live
Data as of 13 May 2026
Open
SAR 102.00
High
SAR 102.00
Low
SAR 102.00
Volume
417
52W High
SAR 129.10
52W Low
SAR 96.65
1W
-3.41%
1M
-2.86%
3M
-3.77%
6M
-1.73%
YTD
-1.73%
1Y
-11.46%

Mīzān Analysis

30/60

Mixed signals — review dimensions carefully

Low Liquidity
Value10.0GrowthHealth9.0Income0.0Momentum4.7Sentiment5.0
9604Sector
Market Cap
209.0M SAR
P/E
10.9
Revenue Growth
Div Yield

Rewards

No standout positive signals at current scores.

Risk Analysis

No significant risk flags at current scores.

Scores computed 13 May 2026

Fundamentals

Market Cap
209.0M SAR
P/E Ratio
10.94
P/B Ratio
EPS
SAR 9.19
EPS Growth
Revenue
83.0M SAR
Revenue Growth
Net Income
18.4M SAR
Profit Margin
36.6%
Debt / Assets
Dividend Yield
Dividend Per Share
SAR 0.00
Shares Outstanding
2.0M
Reporting Period: 2025-12-31Data as of Apr 24, 2026

Mizān Summary

News

Sector News10Industry & macro context
Trade ministers discuss final steps for GCC-UK FTA
Qatar Tribune· 1 day agoNeutralEconomy
UAE launches global plan to reach 42 million people, eradicate river blindness by 2030
Economy Middle East· 3 days agoNeutral
UAE Business: PureHealth surpasses $1.72bn in local procurement spend
Gulf Daily News· 7 days agoEconomy
Bahrain SWF Mumtalakat, SandboxAQ to boost Bahrain’s biotech sector
MSN· 12 days agoNeutralEconomy
Abu Dhabi’s PureHealth Q1 2026 revenue rises 10 percent to $2 billion on global expansion
Economy Middle East· 13 days agoNeutral
Omani delegation visits China to explore high tech pharmaceutical and medical ventures
Times of Oman· 16 days agoNeutralEconomy
Memo to enhance training, employment in pharmaceutical industry inked
وكالة الانباء الاردنية· 23 days agoNeutralEconomy
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
CNBC Business· 27 days agoNeutralMarket Movers
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
CNBC Business· 28 days agoPositiveMarket Movers
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
MarketWatch Top Stories· 28 days agoPositiveEconomy

Events

No upcoming corporate events